Custom formulations of popular weight loss medications have surged in popularity due to shortages and high costs. Here’s what ...

The availability of compounded GLP-1 drugs shifted after the FDA changed their regulations in April 2025. Here’s what to know.

The global non-sterile compounding pharmacy market size is calculated at USD 6.41 billion in 2025 and is expected to reach ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

Incentivizing innovation requires the protection of intellectual property rights. Allowing compounded pharmacies to sell unauthorized versions undermines these rights.

Boothwyn Pharmacy in Chester County is facing a $1 million fine for compounding GLP-1 medications in uninspected facilities.

A pharmacy in Chester County was fined $1 million producing around 30,000 doses of an injectable weight-loss drug without ...

Drug compounding is often regarded as the process of combining, mixing, or altering ingredients to create a medication tailored to the needs of an individual patient. Compounding includes the ...

Compounding drugs prior to receipt of a valid prescription. Compounding drugs removed from the market for safety reasons. Compounding drugs that are essentially copies of commercially available ...

A state-led investigation found the pharmacy compounded GLP-1 meds five days a week in one building, then sent them to the ...

As drugmakers report high demand and waning supply of pediatric fever-reducers, the FDA posted an immediately-in-effect guidance Jan. 20 to help boost access to ibuprofen oral suspension products.

The world’s deadliest infectious disease urgently requires new and effective antibiotics. Researchers have created a promising new compound that may mark a major step forward in the global effort to ...